Followers | 657 |
Posts | 83597 |
Boards Moderated | 0 |
Alias Born | 05/25/2008 |
Friday, May 19, 2023 4:29:24 PM
Recent OPTN News
- Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/17/2024 04:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 01:01:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:08:33 AM
- Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Optinose Announces Reporting Date for First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/10/2024 06:56:52 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 11:09:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:04:59 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 11:03:13 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/09/2024 11:02:06 AM
- Optinose Announces $55 Million Registered Direct Offering • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million • GlobeNewswire Inc. • 04/25/2024 11:00:00 AM
- Optinose to Present at the Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps • GlobeNewswire Inc. • 03/15/2024 07:34:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:10:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/07/2024 09:32:26 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 12:01:38 PM
- Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights • GlobeNewswire Inc. • 03/07/2024 12:00:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 12:00:28 PM
- Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results • GlobeNewswire Inc. • 02/29/2024 09:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:07:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:06:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:04:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 12:08:51 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/22/2024 09:28:22 PM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONG • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM